Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C-Reference-Cited by-同舟云学术

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C

Published:2021-02-08 Issue:8 Volume:41 Page:1802-1814
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Di Maio Velia Chiara¹,Barbaliscia Silvia¹,Teti Elisabetta²,Fiorentino Gianluca³,Milana Martina⁴,Paolucci Stefania⁵,Pollicino Teresa⁶^ORCID,Morsica Giulia⁷^ORCID,Starace Mario⁸,Bruzzone Bianca⁹,Gennari William¹⁰,Micheli Valeria¹¹,Yu La Rosa Katia¹,Foroghi Luca²,Calvaruso Vincenza¹²^ORCID,Lenci Ilaria⁴,Polilli Ennio¹³,Babudieri Sergio¹⁴^ORCID,Aghemo Alessio¹⁵^ORCID,Raimondo Giovanni⁶^ORCID,Sarmati Loredana²,Coppola Nicola⁸¹⁶^ORCID,Pasquazzi Caterina³,Baldanti Fausto⁵,Parruti Giustino¹³,Perno Carlo Federico¹⁷,Angelico Mario⁴,Craxì Antonio¹²,Andreoni Massimo²,Ceccherini‐Silberstein Francesca¹^ORCID,Andreone P,Aragri M,Bertoli A,Boeri E,Brancaccio G,Brunetto M,Callegaro AP,Cenderello G,Cento V,Ciaccio A,Ciancio A,Cuomo N,De Santis A,Di Biagio A,Di Marco V,Di Perri G,Di Stefano MA,Gaeta GB,Ghisetti V,Gulminetti R,Lampertico P,Landonio S,Lichtner M,Lleo A,Maida I,Marenco S,Masetti C,Mastroianni C,Minichini C,Milano E,Monno L,Novati S,Pace Palitti V,Paternoster C,Pellicelli A,Pieri A,Puoti M,Rizzardini G,Ruggiero T,Rossetti B,Sangiovanni V,Santantonio T,Taliani G,Toniutto P,Vullo V.,Zazzi M,

Affiliation:

1. Department of Experimental Medicine University of Rome Tor Vergata Rome Italy

2. Infectious Diseases University Hospital of Rome Tor Vergata Rome Italy

3. Infectious Diseases Sant’Andrea Hospital – “La Sapienza” Rome Italy

4. Hepatology Unit University Hospital of Rome Tor Vergata Rome Italy

5. Molecular Virology Unit, Microbiology and Virology Department IRCCS Policlinic Foundation San Matteo Pavia Italy

6. Department of Internal Medicine University Hospital of Messina Messina Italy

7. Division of Infectious Diseases IRCCS, Ospedale San Raffaele Milan Italy

8. Laboratory for the identification of prognostic factors of response to the treatment against infectious diseases University of Campania "L. Vanvitelli" Napoli Italy

9. Hygiene Unit IRCCS AOU San Martino‐IST Genoa Italy

10. Microbiology Unit University Hospital of Modena Modena Italy

11. Clinical Microbiology, Virology and Bioemergencies ASST Fatebenefratelli Sacco University Hospital Milan Italy

12. Gastroenterology “P. Giaccone” University Hospital Palermo Italy

13. Infectious Disease Unit Pescara General Hospital Pescara Italy

14. Medical, Surgical and Experimental Sciences University of Sassari Sassari Italy

15. Division of Internal Medicine and Hepatology Humanitas Clinical and Research Center IRCCS Rozzano Italy

16. Department of Mental Health and Public Medicine Infectious Diseases Unit University of Campania “L. Vanvitelli” Naples Italy

17. IRCCS Children Hospital Bambino Gesù Rome Italy

Funder

Bristol-Myers Squibb

Merck Sharp and Dohme

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14797

Reference49 articles.

1. Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes

2. International Committee on Taxonomy of Viruses (ICTV).https://talk.ictvonline.org/ictv_wikis/flaviviridae/w/sg_flavi/56/hcv‐classification. Accessed April 1 2019.

3. Global epidemiology and burden of HCV infection and HCV-related disease

4. Genotype 3 Infection: The Last Stand of Hepatitis C Virus

5. Global genotype distribution of hepatitis C viral infection among people who inject drugs

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

2. Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks;2024-04-10

3. Tools Needed to Support Same-day Diagnosis and Treatment of Current Hepatitis C Infection;The Journal of Infectious Diseases;2023-09-22

4. Seroprevalence and Genotypic Distribution Patterns of Hepatitis C Virus among Infected Patients from Sulaimaniyah Province: Iraq;Journal of Zankoy Sulaimani - Part A;2023-06-20

5. Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing NS5A inhibitors with sofosbuvir/velpatasvir plus ribavirin for 24 weeks;Journal of Clinical Virology Plus;2023-06